Welcome to our dedicated page for UBS Group SEC filings (Ticker: UBS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The UBS Group AG (NYSE: UBS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a foreign private issuer. UBS files annual reports on Form 20-F and frequent reports on Form 6-K, which include news releases, capital and risk reports, earnings materials and other information required under the US Securities Exchange Act of 1934.
Through these filings, investors can review how UBS reports on capital adequacy, risk and liquidity under the Swiss systemically relevant bank framework and Basel III standards. Pillar 3 reports filed via Form 6-K present key metrics such as common equity tier 1 capital, risk-weighted assets, leverage ratios, liquidity coverage ratios and net stable funding ratios, along with discussions of risk management, funding and balance sheet structure.
UBS also uses SEC filings to disclose capital instruments and TLAC-eligible senior unsecured debt, including additional tier 1 instruments and senior notes that contribute to total loss-absorbing capacity. Detailed tables show issue dates, maturities, call dates and amounts recognized in regulatory capital, helping users understand UBS’s funding profile and regulatory capital position.
Filings further document cash tender offers for debt securities, including reference yields and total consideration for specific series of notes, some originally issued by Credit Suisse entities and now assumed by UBS Group AG or UBS AG after mergers. Investors interested in UBS’s liability management activities can follow these 6-K submissions for terms and conditions of offers.
Because UBS is a global wealth manager and the leading universal bank in Switzerland, its SEC filings also address topics such as the integration of Credit Suisse, regulatory developments in Switzerland affecting capital requirements, and organizational changes in the Group Executive Board and Board of Directors. Stock Titan enhances access to these documents with AI-powered summaries that explain the structure and implications of complex filings, including annual reports, quarterly materials and transaction-related disclosures, so users can more quickly interpret what lengthy 20-F and 6-K reports mean for UBS’s risk, capital and governance profile.
UBS Group filed a Form 13F combination report summarizing its institutional holdings. The filing lists 22,771 Form 13F information table entries with a reported aggregate market value of $666,317,424,467. The report identifies 11 other included managers and is signed by Andrew Johnson on 05-05-2026.
UBS Group AG has filed a Form 6‑K to provide its newly registered Articles of Association, setting out its current capital structure and governance rules. The share capital is USD 327,780,516.40, divided into 3,277,805,164 registered shares with a par value of USD 0.10 each.
The Articles authorize conditional capital for employee equity plans and convertible instruments, as well as up to 700,000,000 shares of conversion capital for contingent Financial Market Instruments. They also codify the powers of the General Meeting, Board of Directors and Group Executive Board, and detail the framework for approving and paying compensation.
UBS Group AG filed a Form 6-K providing a snapshot of its capitalization in US dollars under IFRS Accounting Standards as of 31 March 2026 and incorporating this information into existing registration statements.
As of 31 March 2026, UBS Group reported short-term debt issued of USD 97,642m and long-term debt issued of USD 246,279m, for total debt issued of USD 343,922m. Of the long-term debt, USD 21,133m was eligible as high-trigger loss-absorbing additional tier 1 capital instruments, and 88% of total debt was unsecured. Equity attributable to shareholders was USD 92,247m and equity attributable to non-controlling interests was USD 255m, resulting in total capitalization of USD 436,424m, compared with USD 418,984m as of 31 December 2025.
UBS Group AG provides detailed information on its capital instruments and total loss-absorbing capacity as of 31 March 2026. The group reports high-trigger loss-absorbing additional tier 1 capital of USD 23,649m and TLAC-eligible senior unsecured debt of USD 100,583m under the Swiss systemically relevant bank framework.
The tables list each instrument’s issuer, ISIN, currency, outstanding amount, amount recognized in regulatory capital, gone concern eligibility, maturity and first call dates. Footnotes explain treatment of legacy Credit Suisse instruments, amortized face values and adjustments for own-credit-related gains or losses.
UBS Group outlines major potential effects from new Swiss capital rules and proposed changes to the treatment of foreign subsidiaries. Changes to the Capital Adequacy Ordinance will shorten the capital life of software to three years and increase prudential valuation deductions, which UBS estimates will eliminate about USD 4bn of net CET1 capital at Group level and lower its CET1 ratio by roughly 0.8 percentage points.
Separately, a proposal to fully deduct foreign participations from UBS AG’s CET1, phased in over seven years, would require about USD 20bn of additional CET1. Together with around USD 15bn of previously communicated incremental capital linked to the Credit Suisse acquisition, UBS calculates total extra CET1 needs of about USD 37bn, with an annual capital cost of around USD 3bn. UBS describes the package as extreme, warns of economic consequences for Switzerland, but maintains its 2026 targets for an underlying return on CET1 capital of around 15% and a cost/income ratio below 70%, and says it remains committed to planned 2026 capital returns.
UBS Group AG has published the agenda for its 2026 Annual General Meeting, to be held on 15 April 2026 in Basel. The Board proposes an ordinary cash dividend of USD 1.10 per share for the 2025 financial year.
Shareholders will vote on approval of the 2025 financial statements, advisory votes on the 2025 Compensation and Sustainability Reports, compensation budgets for directors and executives, and the discharge of the Board of Directors and Group Executive Board. Most directors, including Chairman Colm Kelleher, are standing for re-election, while Lukas Gähwiler, William C. Dudley and Jeanette Wong will not.
New nominees to the Board are Markus Ronner, Agustín Carstens and Luca Maestri. The agenda also includes re-election of the independent proxy and auditors and an ordinary reduction of share capital through cancellation of shares repurchased under the 2024 share repurchase program.
UBS Group provides its 2025 Sustainability Report, detailing strategy, governance and progress on climate and broader ESG goals across the Group.
UBS reports a 48% reduction in scope 1 and market-based scope 2 emissions versus its 2023 baseline and an 18.8% cut in energy use, with 99.7% of electricity from renewable sources. The bank targets net-zero own operations by 2035 and has lending sector decarbonization targets for Swiss real estate, power, iron and steel, cement and fossil fuels.
Asset Management manages USD 111.5 billion in net‑zero‑ambition portfolios and sustainable investing assets across the firm rose to USD 405.6 billion. UBS exceeded its philanthropy goals, channeling USD 1.6 billion in donations via the UBS Optimus network since 2021 and reaching 33.5 million people by the end of 2025. The report also highlights integration progress with Credit Suisse, expanded AI initiatives, and detailed sustainability governance and risk frameworks.
UBS Group furnished its 31 December 2025 Pillar 3 report, detailing risk, capital and liquidity under the final Basel III standards in Switzerland. The adoption of these standards reduced Group risk‑weighted assets (RWA) by USD 8.6bn, as higher market risk RWA were more than offset by lower operational, credit and counterparty credit risk RWA.
Swiss regulatory proposals could require about USD 22bn of additional common equity tier 1 (CET1) capital at UBS AG, and around USD 37bn in total extra CET1 when including post‑acquisition capital needs for Credit Suisse. UBS reported CET1 capital of USD 71.3bn, a CET1 ratio of 14.44%, total RWA of USD 493.4bn, available TLAC of USD 187.3bn and a Basel III leverage ratio of 5.62%.
The Group’s average liquidity coverage ratio was 182.64% and its net stable funding ratio was 116.08%, both above prudential requirements. For 2025, the Board plans to propose a dividend of USD 1.10 per share, completed share repurchases of USD 3bn in 2025, and intends to repurchase a further USD 3bn of shares in 2026, with a stated commitment to progressive dividends.
UBS Group AG filed a Form 6-K providing an updated view of its consolidated capitalization under IFRS in US dollars. As of 31 December 2025, UBS reported short-term debt issued of USD 92,096 million and long-term debt issued of USD 236,405 million, for total debt issued of USD 328,501 million.
Equity attributable to shareholders was USD 90,213 million and equity attributable to non-controlling interests was USD 271 million, giving total capitalization of USD 418,984 million. Of the total debt issued at year-end 2025, 88% was unsecured. UBS also states that this report is incorporated by reference into its existing Form F-3 and multiple Form S-8 registration statements and related prospectuses.
UBS Group AG reports strong 2025 standalone results, with net profit of $13,070m (CHF 10,363m), up from $2,994m in 2024. The increase is mainly driven by much higher dividend income from subsidiaries and interest income on onward lending funded by AT1 and TLAC debt.
Dividend income from subsidiaries rose to $13,349m, while financial income reached $6,481m. The Board proposes a cash dividend of $1.10 per share, split equally between total profit and the capital contribution reserve, after cancelling 120,506,008 shares repurchased under the 2022 buyback.